Bold claim: Camel-derived peptides could be a new frontline against drug-resistant bacteria. February 16, 2026—Antimicrobial resistance is evolving into a global health emergency, with far too few new antibiotics in the pipeline. Researchers at Sultan Qaboos University have identified three new antimicrobial peptides (AMPs) from dromedary camels that effectively act against multidrug-resistant bacteria, offering promising alternatives to conventional drugs.
The findings, published in Frontiers in Immunology (Volume 17, January 21, 2026), combine computational predictions with laboratory validation. The team performed colony-forming assays, tests of membrane permeability, and electron microscopy on resistant strains such as MRSA and MDR E. coli to verify the peptides’ activity.
Two peptides, CdPG-3 and CdCATH, showed strong antibacterial effects against both Gram-positive and Gram-negative bacteria. They appear to damage bacterial membranes and cause leakage, while remaining not highly toxic to camel or human red blood cells at lower doses.
Camels’ robust innate immune system, including these cathelicidin-like AMPs, could explain their relative resistance to infections that commonly affect other ruminants. The researchers emphasize that this work lays the groundwork for developing camel-derived AMPs as therapeutics against resistant pathogens.
Unlike traditional antibiotics, which target specific bacterial components and can drive resistance through target mutations, AMPs tend to disrupt membranes in a broad, less mutation-prone manner. The peptides exhibited low hemolytic activity in relevant species, supporting their safety profile for further development.
Looking ahead, the researchers plan to optimize these AMPs for clinical use, leveraging Oman’s camel resources to scale up potential therapies.
Public release note: This material originates from the study authors and organizations and has been edited for clarity and length. Mirage.News does not endorse any institutional position; all views and conclusions are those of the authors. View the full article here: https://www.miragenews.com/camel-peptides-battle-drug-resistant-bacteria-1624142/
